Introduction
============

Lung cancer is the most commonly diagnosed type of cancer and has the highest mortality rate, leading to approximately 1.38 million deaths in the world per year.[@b1-ott-11-2419] Studies show that smoking is the primary risk factor for lung cancer. However, although more than 80% of lung cancer patients have smoked, only 15% of smokers will eventually be diagnosed with lung cancer, indicating that other factors such as genetic predisposition, contribute to the development of lung cancer.[@b2-ott-11-2419]

MicroRNAs (miRNAs) are an abundant category of endogenous small noncoding RNAs of about 18--25 nucleotides in length, which negatively regulate their target mRNAs via posttranscriptional gene silencing.[@b3-ott-11-2419] Studies have shown that about 70% of mammalian miRNAs are located in transcription units, mostly in intron regions.[@b4-ott-11-2419] miRNAs are present in various forms, and mature miRNAs exert a broad range of biological effects by binding to the mRNA of the target gene. Research suggests that miRNA regulates up to 30% of human genes,[@b5-ott-11-2419] and accumulating evidence supports a significant association between miRNAs and the risk and prognosis of lung cancer.[@b6-ott-11-2419],[@b7-ott-11-2419] Takamizawa et al reported that lower expression of the let-7 miRNAs aggravated lung cancer,[@b8-ott-11-2419] while Hayashita et al found that upregulation of the miRNA-17-92 may decrease lung cancer risk.[@b9-ott-11-2419]

Single-nucleotide polymorphisms (SNPs) can change the properties of miRNAs, thereby influencing an individual's susceptibility to cancers.[@b10-ott-11-2419]--[@b12-ott-11-2419] The miRNA-146a rs2910164[@b13-ott-11-2419] and miRNA-196a2 rs11614913 polymorphisms,[@b14-ott-11-2419] in particular, have been found to be relevant to lung cancer susceptibility. However, the conclusions of the published studies are often in conflict.[@b15-ott-11-2419],[@b16-ott-11-2419] For example, Volpe et al found that miRNA-196a2 regulated the *HOX* gene family, which is associated with lung cancer metastasis. miRNA-196a2 rs11614913 polymorphisms regulated the expression of miRNA-196a2 itself and influenced the risk of lung cancer.[@b15-ott-11-2419] However, Vinci et al did not find any connection between miRNA-196a2 rs11614913 polymorphisms and the risk of lung cancer, although they did find that miRNA-146a rs2910164 polymorphisms had a role in enhancing the risk of lung cancer.[@b16-ott-11-2419]

Therefore, in this study, a meta-analysis of previously and newly published data was performed to further explore the correlation between SNPs of miRNA-146a rs2910164 and miRNA-196a2 rs11614913 and lung cancer risk.

Materials and methods
=====================

Literature retrieval method
---------------------------

We searched the relevant published literature from January 1, 2007, to April 30, 2017, in English or Chinese, using the PubMed, EMBASE, China National Knowledge Infrastructure, and WanFang databases, with the following keywords: "lung cancer", "miRNA-146a", "miRNA-196a2", "polymorphism", "rs2910164", and "rs11614913". References of the retrieved articles were published in the primary literature and had no distinct overlap of population with other studies. The inclusion criteria were as follows: 1) case-control study; 2) case group for the diagnosis of lung cancer patients and control group for non-lung cancer population; and 3) data on the miRNA-196a2 rs11614913 and miRNA-146a rs2910164 polymorphisms. We excluded reports with the same data or overlapping data by the same authors.

Data extraction
---------------

Two reviewers extracted data from eligible studies in duplicate with a standard data collection form and reached a consensus on each item. The following information was extracted for each study: first author, publication date, country, ethnicity, source of control, genotype of miRNA-196a2 rs11614913, and miRNA-146a rs2910164 polymorphism.

Statistical analysis
--------------------

Odds ratios (ORs) and 95% confidence intervals (CIs) were used to measure the degree of correlation between the polymorphism of rs2910164 or rs11614913 and the genetic susceptibility to lung cancer. All analyses used the wild genotype as a control. The combined OR values for CC vs TT, CC vs GG, CT vs TT, and CG vs GG, respectively, were calculated.

The combined OR value was calculated using a *z*-test with a significance level of *P* = 0.05. The *Q* value and *I*^2^ value were used to evaluate the heterogeneity between the results of the study. The calibrated *Q*-test based on the chi-square test was used to evaluate whether the distribution of effects of each study had significant heterogeneity. With *α* = 0.10 as the demarcation standard, the heterogeneity of the effect of the study was not statistically significant at *P* \> 0.1, and the study results were merged by the Mantel-Haenszel method. When *P* ≤ 0.1, a random-effects model (inverse-variance method) was used to combine the results. *I*^2^ was used to describe the proportion of the variation between the studies accounting for total variation.

Publication bias was assessed by visual inspection of the Begg's funnel plot. If the funnel plot was symmetrical, it was considered that there was no publication bias in the literature being considered; otherwise, it was considered biased. Our Begg's funnel plot presented a symmetrical and funnel-like distribution of points, indicating that the publication bias risk was low in this analysis. Subgroup analyses were conducted to investigate the association of the subgroups and to identify any heterogeneity.

Results
=======

Study characteristics
---------------------

We searched the online databases using search criteria related to miRNA-196a2 rs11614913 and miRNA-146a rs2910164 SNPs and the risk of lung cancer. Thirteen published articles were initially collected. Four studies were excluded after duplicate removal, primary screening by reading titles and abstracts, and secondary screening by intensive reading. One of these was written by Tian and its data overlapped.[@b17-ott-11-2419] One only reported survival times,[@b18-ott-11-2419] one performed a meta-analysis,[@b19-ott-11-2419] and another did not report sufficient related data.[@b20-ott-11-2419] In total, nine studies met our inclusion criteria. Of these, seven were about miRNA-196a2 rs11614913, with a cumulative case group of 3,101 participants and a control group of 3,234. Six studies were about miRNA-146a rs2910164, with 3,483 and 3,578 participants in the case and control groups, respectively ([Table 1](#t1-ott-11-2419){ref-type="table"}).

Meta-analysis statistic results of miRNA-196a2 rs11614913
---------------------------------------------------------

In the CC vs TT group, the heterogeneity test demonstrated the following: *χ*^2^ = 10.03, *P* = 0.12. The heterogeneity was not significant. The OR was 1.25, with a 95% CI of 1.09--1.44, and *P* = 0.002 using the fixed-effects model. The results showed that people with the CC genotype had an increased risk of lung cancer, and that the difference was statistically significant. For the CT vs TT group, the heterogeneity test demonstrated the following: *χ*^2^ = 13.07, *P* = 0.04, *I*^2^ = 54%, with moderate to high heterogeneity. The OR was 1.26, with a 95% CI of 1.03--1.53, and *P* = 0.02 according to the random-effects model. The results showed that individuals with the CT genotype had an increased risk of lung cancer, and that the difference was statistically significant ([Figure 1](#f1-ott-11-2419){ref-type="fig"}). A Begg's funnel plot was constructed to evaluate the publication bias of the literature; the results indicated that no obvious publication bias affected this meta-analytic review ([Figure 2](#f2-ott-11-2419){ref-type="fig"}).

Meta-analysis statistic results of miRNA-146a rs2910164
-------------------------------------------------------

For the CC vs GG group, the heterogeneity test showed that *χ*^2^ = 2.64, *P* = 0.75, and that the heterogeneity was not significant. The OR was 1.30, with a 95% CI of 1.13--1.49, and *P* = 0.0002 according to the fixed-effects model, and the difference was statistically significant. The results showed that individuals with the CC genotype had an increased risk of lung cancer, and the difference was statistically significant. For the CG vs GG group, the heterogeneity test showed that *χ*^2^ = 4.05, *P* = 0.54, and the heterogeneity was not significant. The OR was 1.08, with a 95% CI of 0.96--1.22, and *P* = 0.18 according to the fixed-effects model ([Figure 3](#f3-ott-11-2419){ref-type="fig"}). A Begg's funnel plot was constructed; again, there was no observed publication bias in this study ([Figure 4](#f4-ott-11-2419){ref-type="fig"}).

Results of subgroup analysis by ethnicity
-----------------------------------------

Stratified analyses significantly reduced the heterogeneity of the subgroups. The results of subgroup analysis by ethnicity are shown in [Table 2](#t2-ott-11-2419){ref-type="table"}. There was only one study of ethnicity for Caucasians, and so no heterogeneity test was performed for Caucasian subgroups.

A significant increased risk of lung cancer based on ethnicity was found. For miRNA-196a2 rs11614913, the CC and CT genotypes were associated with increased susceptibility to lung cancer in the Asian population compared with the TT genotype, with a statistically significant difference; however, in the Caucasian population, no polymorphism of this locus was observed to be connected with susceptibility to lung cancer.

For miRNA-146a rs2910164, compared with the GG genotype, the CC genotype was associated with an increased susceptibility to lung cancer in the Asian population, with a statistically significant difference. Based on the current sample size, there was no correlation in Caucasians. The CC genotype was not associated with susceptibility to lung cancer in the Asian population, but CG genotype of Caucasians was associated with an increased risk of lung cancer, with a statistically significant difference.

Results of subgroup analysis by country
---------------------------------------

The results of subgroup analysis by country are shown in [Table 3](#t3-ott-11-2419){ref-type="table"}.

For miRNA-196a2 rs11614913, the CC genotype was not associated with an increased susceptibility to lung cancer compared with the TT genotype in either the Chinese or the Italian subgroup, whereas in the Korean subgroup, an association was found. The CT genotype was not connected with lung cancer risk in any country subgroup.

For miRNA-146a rs2910164, the CC genotype was associated with an increased susceptibility to lung cancer compared with the GG genotype in both the Chinese and Korean subgroups, and the difference was statistically significant. In the Italian subgroup, the CC genotype was not associated with lung cancer susceptibility. However, the CG genotype was associated with an increased susceptibility to lung cancer only in the Italian subgroup.

Results of subgroup analysis by source of control group
-------------------------------------------------------

The association between SNPs and genetic susceptibility to lung cancer may also depend on the source of the control group. The results of the subgroup analysis according to the source of control group are shown in [Table 4](#t4-ott-11-2419){ref-type="table"}.

For miRNA-196a2 rs11614913, the CC genotype was not associated with an elevated susceptibility to lung cancer compared with TT genotype in either the community or hospital subgroups. The CT genotype was associated with an increased susceptibility to lung cancer in the hospital control subgroup, but not in the community subgroup, and the difference was statistically significant.

For miRNA-146a rs2910164, the CC genotype was associated with an increased susceptibility to lung cancer compared with the GG genotype in both the community and hospital control groups, and the difference was statistically significant. However, the CG genotype was not connected with an increased susceptibility to lung cancer in either subgroup.

Discussion
==========

Lung cancer is the most commonly diagnosed cancer, as well as the chief cause of cancer deaths globally. In addition to environmental exposure, SNPs can make an individual more susceptible to lung cancer. Therefore, there is a need to seek out valid biomarkers to predict the risk of the disease.

miRNAs are endogenous small RNAs of about 18--25 nucleotides in length. Previous studies have shown that miRNAs have important roles in key biological processes and are considered a key factor in tumorigenesis.[@b29-ott-11-2419]

Many researchers have aimed to understand the role of SNPs that occur in precursor and mature miRNAs, and their effects on gene function or expression, cancer susceptibility, and progression of various diseases.[@b30-ott-11-2419] Identifying SNPs is important in predicting the risks of individuals and understanding the pathogenesis of cancer. Many studies have explored the common SNPs of miRNAs and their associations with risk of various cancers, including lung cancer.[@b31-ott-11-2419]--[@b36-ott-11-2419] However, the mechanisms of carcinogenesis are complex, and the investigations on single genetic polymorphisms and studies with small sample sizes that have been performed so far have not provided a means to reliably predict the risk of cancer. In addition, the conclusions of previous studies have sometimes been inconsistent and conflicted with each other.[@b16-ott-11-2419],[@b22-ott-11-2419],[@b37-ott-11-2419],[@b38-ott-11-2419] To address this, we carried out a meta-analysis by gathering all of the studies that reported a connection between the miRNA-196a2 rs11614913 and miRNA-146a rs2910164 SNPs and the risk of lung cancer.

For the miRNA-196a2 rs11614913 locus, we found that the risk of lung cancer in the CC and CT genotype individuals was higher than in the TT genotype individuals. For the miRNA-146a rs2910164 locus, individuals with the CC genotype exhibited a higher risk of lung cancer than individuals with the GG genotype. Thus, the miRNA-196a2 rs11614913 and miRNA-146a rs2910164 loci can serve as potential candidate sites for lung cancer susceptibility screening.

To identify any differences between individuals of Caucasian and Asian ethnicities, we carried out a subgroup analysis. This showed that different ethnicity, to some extent, was linked to differences in the association between genetic polymorphisms and lung cancer risk. On this basis, a further subgroup analysis by country was performed -- this was, to our knowledge, the first attempt to explore whether the susceptibility to lung cancer varies across different countries. We considered that the dietary and health-related habits of different countries might influence the risk of lung cancer. As there was only one study of Caucasian individuals and the participants in this study were Italian, the Italian subgroup was identical to the Caucasian subgroup. Our results indicated that the association between the miRNA-196a2 rs11614913 polymorphism and the risk of lung cancer only could be found in Asian populations. Our initial results indicated that the predictive value of miRNA-196a2 rs11614913 polymorphism was valid in Asian people. However, in the subgroup analysis of correlations between polymorphisms and countries, this relationship was found only in Korean individuals. Differences owing to ethnicity have also been found in other types of cancer.[@b39-ott-11-2419] Wang et al[@b39-ott-11-2419] found that the miRNA-196a2 rs11614913 CC genotype was significantly associated with breast cancer risk in Chinese and Indian individuals, but not in Caucasians. For the miRNA-146a rs2910164 locus, only the CC genotype was related to an increased susceptibility of lung cancer compared with the GG genotype in the Asian population, whereas the CG genotype of the Caucasian population was associated with an increased susceptibility of lung cancer compared with the GG genotype. After subgroup analysis based on the country, the CC genotype was associated with an increased susceptibility to lung cancer compared with GG genotype in both the Chinese and Korean subgroups. As there was only one report involving Caucasian population,[@b16-ott-11-2419] and the sample size of this study was relatively small, further research is needed before any firm conclusions can be drawn regarding this population.

According to the subgroup analysis of the control source, the miRNA-196a2 rs11614913 CT genotype was associated with an increased susceptibility compared with the TT genotype in the hospital subgroup. By contrast, the miRNA-146a rs2910164 CC genotype was associated with a higher risk of lung cancer compared with the GG genotype in both community and hospital subgroups.

There were some advantages of the comprehensive analysis that we have performed here, such as the use of the funnel plot to evaluate publication bias, which showed good funnel plot symmetry. In addition, all of the nine articles in our study were of high quality. However, some limitations still need to be addressed. First, and most importantly, the results of the meta-analysis were limited by the available literature, such as the number of documents, quality, and sample size, which may affect its validity. For example, there were too few Caucasian studies available, and the heterogeneity among different studies cannot be ignored. Furthermore, we did not explore the association of SNP-SNP interactions. Such gene--gene interactions in cancers have been reported in the literature.[@b40-ott-11-2419]--[@b43-ott-11-2419] In addition, lung cancer is a result of gene--environment interactions. In this study, only the influence of genetic factors was taken into account, and environmental factors, such as smoking and air pollution, were not explored. Future work examining these gene--gene and gene--environment interactions and their association with lung cancer is needed.

In summary, our meta-analysis suggested that the miRNA-196a2 rs11614913 CC and CT genotypes, and the miRNA-146a rs2910164 CC genotype, may increase the risk of lung cancer, especially in Asian populations. Owing to the low number of studies included and the relatively small sample size of the single Caucasian study, the negative results in Caucasian individuals need to be confirmed by further study. Overall, it will be necessary to confirm all these findings using well-designed and larger sample size studies. In addition, the interaction of genetic and environmental factors should be considered.
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###### 

Characteristics of researches included in the meta-analysis

  Study                           Country (ethnicity)   Source of control   Methods        miRNA SNP          Number of subjects   Case   Control                     
  ------------------------------- --------------------- ------------------- -------------- ------------------ -------------------- ------ --------- ----- ----- ----- -----
  Yin et al[@b21-ott-11-2419]     Chinese (Asian)       H                   TaqMan PCR     196a2 rs11614913   1,183                149    298       128   178   297   133
  Shang et al[@b22-ott-11-2419]   Chinese (Asian)       P                   PCR-RFLP       196a2 rs11614913   116                  7      17        8     48    26    10
  Yin et al[@b23-ott-11-2419]     Chinese (Asian)       H                   TaqMan PCR     196a2 rs11614913   568                  67     141       50    97    150   63
  Vinci et al[@b16-ott-11-2419]   Italian (Caucasian)   H                   PCR-HRMA       196a2 rs11614913   230                  12     54        35    10    61    58
  Hong et al[@b24-ott-11-2419]    Korean (Asian)        P                   TaqMan PCR     196a2 rs11614913   834                  96     224       86    134   198   96
  Kim et al[@b25-ott-11-2419]     Korean (Asian)        H                   Fluorescence   196a2 rs11614913   1,294                162    305       187   185   300   155
  Tian et al[@b26-ott-11-2419]    Chinese (Asian)       P                   PCR-RFLP       196a2 rs11614913   2,093                293    512       253   307   519   209
  Yin et al[@b21-ott-11-2419]     Chinese (Asian)       H                   TaqMan PCR     146a rs2910164     1,183                97     280       198   127   313   168
  Yin et al[@b23-ott-11-2419]     Chinese (Asian)       H                   TaqMan PCR     146a rs2910164     568                  45     134       79    63    160   87
  Jia et al[@b27-ott-11-2419]     Chinese (Asian)       H                   PCR-RFLP       146a rs2910164     800                  64     182       154   76    200   124
  Jeon et al[@b28-ott-11-2419]    Korean (Asian)        P                   PCR-RFLP       146a rs2910164     2,187                223    500       368   244   540   312
  Vinci et al[@b16-ott-11-2419]   Italian (Caucasian)   H                   PCR-HRMA       146a rs2910164     230                  44     48        9     73    45    11
  Tian et al[@b26-ott-11-2419]    Chinese (Asian)       P                   PCR-RFLP       146a rs2910164     2,093                360    510       188   364   502   169

**Abbreviations:** miRNA, microRNA; SNP, single-nucleotide polymorphism; P, population; H, hospital; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; HRMA, high resolution melting analysis.

###### 

Subgroup analysis of correlation between polymorphisms and ethnicity

  miRNA SNP          Ethnicity   Comparison   *χ*^2^   *P*~hetero~   *I*^2^ (%)   *P*-value        OR           95% CI
  ------------------ ----------- ------------ -------- ------------- ------------ ---------------- ------------ ----------------
  196a2 rs11614913   Asian       CC vs TT     6.31     0.28          21           **0.003**        **1.29**     **1.09--1.52**
  CT vs TT           11.97       0.04         58       **0.01**      **1.29**     **1.05--1.58**                
  Caucasian          CC vs TT    --           --       --            0.15         0.50             0.20--1.29   
  CT vs TT           --          --           --       0.51          0.74         0.30--1.84                    
  146a rs2910164     Asian       CC vs GG     2.63     0.62          0            **0.0002**       **1.30**     **1.13--1.49**
  CG vs GG           0.87        0.93         0        0.35          1.06         0.94--1.19                    
  Caucasian          CC vs GG    --           --       --            0.53         1.36             0.52--3.53   
  CG vs GG           --          --           --       **0.04**      **1.77**     **1.02--3.08**                

**Note:** Bold values are statistically significant.

**Abbreviations:** miRNA, microRNA; SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval.

###### 

Subgroup analysis of correlation between polymorphisms and countries

  miRNA SNP          Country    Comparison   *χ*^2^   *P*~hetero~   *I*^2^ (%)   *P*-value        OR               95% CI
  ------------------ ---------- ------------ -------- ------------- ------------ ---------------- ---------------- ----------------
  196a2 rs11614913   Chinese    CC vs TT     6.01     0.11          50           0.08             1.30             0.97--1.75
  CT vs TT           8.98       0.03         67       0.09          1.30         0.96--1.75                        
  Korean             CC vs TT   0.15         0.70     0             **0.02**     **1.33**         **1.05--1.69**   
  CT vs TT           2.08       0.15         52       0.06          1.33         0.99--1.80                        
  Italian            CC vs TT   --           --       --            0.15         0.50             0.20--1.29       
  CT vs TT           --         --           --       0.51          0.74         0.30--1.84                        
  146a rs2910164     Chinese    CC vs GG     2.63     0.45          0            **0.003**        **1.30**         **1.10--1.54**
  CG vs GG           0.66       0.88         0        0.30          1.08         0.93--1.24                        
  Korean             CC vs GG   --           --       --            **0.03**     **1.29**         **1.02--1.63**   
  CG vs GG           --         --           --       0.91          1.01         0.81--1.26                        
  Italian            CC vs GG   --           --       --            0.53         1.36             0.52--3.53       
  CG vs GG           --         --           --       **0.04**      **1.77**     **1.02--3.08**                    

**Note:** Bold values are statistically significant.

**Abbreviations:** miRNA, microRNA; SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval.

###### 

Subgroup analysis of correlation between polymorphisms and source of control

  miRNA SNP          Source of control   Comparison   *χ*^2^   *P*~hetero~   *I*^2^ (%)   *P*-value        OR               95% CI
  ------------------ ------------------- ------------ -------- ------------- ------------ ---------------- ---------------- ----------------
  196a2 rs11614913   Population          CC vs TT     5.40     0.07          63           0.08             1.47             0.95--2.28
  CT vs TT           11.51               0.003        83       0.09          1.58         0.93--2.70                        
  Hospital           CC vs TT            4.21         0.24     29            0.22         1.17             0.91--1.50       
  CT vs TT           1.55                0.67         0        **0.04**      **1.19**     **1.01--1.41**                    
  146a rs2910164     Population          CC vs GG     0.60     0.44          0            **0.03**         **1.21**         **1.02--1.44**
  CG vs GG           0.01                0.93         0        0.78          1.02         0.88--1.18                        
  Hospital           CC vs GG            0.44         0.93     0             **0.001**    **1.45**         **1.16--1.81**   
  CG vs GG           2.21                0.53         0        0.06          1.21         0.99--1.48                        

**Note:** Bold values are statistically significant.

**Abbreviations:** miRNA, microRNA; SNP, single-nucleotide polymorphism; OR, odds ratio; CI, confidence interval.
